As of January 22, 2025, Kezar Life Sciences (KZR) has a market cap of $46.696 million USD. According to our data, Kezar Life Sciences is ranked No.8198 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $46.70 M |
-4.76%
|
Dec 31, 2024 | $49.03 M |
-29.26%
|
Dec 29, 2023 | $69.31 M |
-86.51%
|
Dec 30, 2022 | $0.51 B |
-57.89%
|
Dec 31, 2021 | $1.22 B |
220.31%
|
Dec 31, 2020 | $0.38 B |
30.17%
|
Dec 31, 2019 | $0.29 B |
-83.01%
|
Dec 31, 2018 | $1.72 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Aurinia Pharmaceuticals
AUPH
|
$1.11 B |
0.000 M
|
Canada
|
Corbus Pharmaceuticals
CRBP
|
$0.14 B |
-0.000 M
|
USA
|
Equillium
EQ
|
$22.32 M |
0.000 M
|
USA
|
Gossamer Bio
GOSS
|
$0.20 B |
0.000 M
|
USA
|
Immunovant
IMVT
|
$3.93 B |
-0.000 M
|
USA
|
Kiniksa Pharmaceuticals
KNSA
|
$1.39 B |
0.588 B
|
|
Morphic Therapeutic
MORF
|
$2.86 B |
0.000 M
|
USA
|
Omeros Corporation
OMER
|
$0.54 B |
0.000 M
|
USA
|
Rigel Pharmaceuticals
RIGL
|
$0.38 B |
-0.000 M
|
USA
|
TG Therapeutics
TGTX
|
$4.54 B |
0.000 M
|
USA
|
Market Cap | = | KZR Stock Price | * | KZR Shares Outstanding |
= | $6.40 | * | 7.30 M | |
= | $46.70 M |